rs121913237
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913237
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913237
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913237
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913237
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Development of molecular biomarkers in individualized treatment of colorectal cancer.
|
21729679 |
2011 |
rs121913237
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.
|
21305640 |
2011 |
rs121913237
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.
|
21305640 |
2011 |
rs121913237
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Development of molecular biomarkers in individualized treatment of colorectal cancer.
|
21729679 |
2011 |
rs121913237
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Development of molecular biomarkers in individualized treatment of colorectal cancer.
|
21729679 |
2011 |
rs121913237
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.
|
21829508 |
2011 |
rs121913237
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.
|
21829508 |
2011 |
rs121913237
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.
|
21305640 |
2011 |
rs121913237
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.
|
21829508 |
2011 |
rs121913237
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
|
20619739 |
2010 |
rs121913237
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
|
20619739 |
2010 |
rs121913237
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
NRAS mutations are rare in colorectal cancer.
|
20736745 |
2010 |
rs121913237
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
|
20619739 |
2010 |
rs121913237
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
NRAS mutations are rare in colorectal cancer.
|
20736745 |
2010 |
rs121913237
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
NRAS mutations are rare in colorectal cancer.
|
20736745 |
2010 |
rs121913237
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models.
|
17699718 |
2007 |
rs121913237
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models.
|
17699718 |
2007 |
rs121913237
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models.
|
17699718 |
2007 |
rs121913237
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
BRAF mutation predicts sensitivity to MEK inhibition.
|
16273091 |
2006 |
rs121913237
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
BRAF mutation predicts sensitivity to MEK inhibition.
|
16273091 |
2006 |
rs121913237
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
BRAF mutation predicts sensitivity to MEK inhibition.
|
16273091 |
2006 |